Antenatal Syphilis Screening Using Point-of-Care Testing in Sub-Saharan African Countries: A Cost-Effectiveness Analysis
Background:
Untreated syphilis in pregnancy is associated with adverse clinical outcomes for the infant. Most syphilis infections occur in sub-Saharan Africa (SSA), where coverage of antenatal screening for syphilis is inadequate. Recently introduced point-of-care syphilis tests have high accuracy and demonstrate potential to increase coverage of antenatal screening. However, country-specific cost-effectiveness data for these tests are limited. The objective of this analysis was to evaluate the cost-effectiveness and budget impact of antenatal syphilis screening for 43 countries in SSA and estimate the impact of universal screening on stillbirths, neonatal deaths, congenital syphilis, and disability-adjusted life years (DALYs) averted.
Methods and Findings:
The decision analytic model reflected the perspective of the national health care system and was based on the sensitivity (86%) and specificity (99%) reported for the immunochromatographic strip (ICS) test. Clinical outcomes of infants born to syphilis-infected mothers on the end points of stillbirth, neonatal death, and congenital syphilis were obtained from published sources. Treatment was assumed to consist of three injections of benzathine penicillin. Country-specific inputs included the antenatal prevalence of syphilis, annual number of live births, proportion of women with at least one antenatal care visit, per capita gross national income, and estimated hourly nurse wages. In all 43 sub-Saharan African countries analyzed, syphilis screening is highly cost-effective, with an average cost/DALY averted of US$11 (range: US$2–US$48). Screening remains highly cost-effective even if the average prevalence falls from the current rate of 3.1% (range: 0.6%–14.0%) to 0.038% (range: 0.002%–0.113%). Universal antenatal screening of pregnant women in clinics may reduce the annual number of stillbirths by up to 64,000, neonatal deaths by up to 25,000, and annual incidence of congenital syphilis by up to 32,000, and avert up to 2.6 million DALYs at an estimated annual direct medical cost of US$20.8 million.
Conclusions:
Use of ICS tests for antenatal syphilis screening is highly cost-effective in SSA. Substantial reduction in DALYs can be achieved at a relatively modest budget impact. In SSA, antenatal programs should expand access to syphilis screening using the ICS test.
Please see later in the article for the Editors' Summary
Vyšlo v časopise:
Antenatal Syphilis Screening Using Point-of-Care Testing in Sub-Saharan African Countries: A Cost-Effectiveness Analysis. PLoS Med 10(11): e32767. doi:10.1371/journal.pmed.1001545
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1001545
Souhrn
Background:
Untreated syphilis in pregnancy is associated with adverse clinical outcomes for the infant. Most syphilis infections occur in sub-Saharan Africa (SSA), where coverage of antenatal screening for syphilis is inadequate. Recently introduced point-of-care syphilis tests have high accuracy and demonstrate potential to increase coverage of antenatal screening. However, country-specific cost-effectiveness data for these tests are limited. The objective of this analysis was to evaluate the cost-effectiveness and budget impact of antenatal syphilis screening for 43 countries in SSA and estimate the impact of universal screening on stillbirths, neonatal deaths, congenital syphilis, and disability-adjusted life years (DALYs) averted.
Methods and Findings:
The decision analytic model reflected the perspective of the national health care system and was based on the sensitivity (86%) and specificity (99%) reported for the immunochromatographic strip (ICS) test. Clinical outcomes of infants born to syphilis-infected mothers on the end points of stillbirth, neonatal death, and congenital syphilis were obtained from published sources. Treatment was assumed to consist of three injections of benzathine penicillin. Country-specific inputs included the antenatal prevalence of syphilis, annual number of live births, proportion of women with at least one antenatal care visit, per capita gross national income, and estimated hourly nurse wages. In all 43 sub-Saharan African countries analyzed, syphilis screening is highly cost-effective, with an average cost/DALY averted of US$11 (range: US$2–US$48). Screening remains highly cost-effective even if the average prevalence falls from the current rate of 3.1% (range: 0.6%–14.0%) to 0.038% (range: 0.002%–0.113%). Universal antenatal screening of pregnant women in clinics may reduce the annual number of stillbirths by up to 64,000, neonatal deaths by up to 25,000, and annual incidence of congenital syphilis by up to 32,000, and avert up to 2.6 million DALYs at an estimated annual direct medical cost of US$20.8 million.
Conclusions:
Use of ICS tests for antenatal syphilis screening is highly cost-effective in SSA. Substantial reduction in DALYs can be achieved at a relatively modest budget impact. In SSA, antenatal programs should expand access to syphilis screening using the ICS test.
Please see later in the article for the Editors' Summary
Zdroje
1. MantoyaPJ, LukehartSA, BrentlingerPE, BlancoAJ, FlorianoF, et al. (2006) Rapid point-of-care tests, enzyme immunoassays, and chemiluminescence assays. Bull World Health Organ 84: 97–104.
2. SombiéI, MedaN, CartouxM, TiendrébéogoS, OuangréA, et al. (2000) Seroprevalence of syphilis among women attending urban antenatal clinics in Burkina Faso, 1995–8. Sex Transm Inf 76: 314–316.
3. Watson-JonesD, ChangaluchaJ, GumodokaB, WeissH, RusizokaM, et al. (2002) Syphilis in pregnancy in Tanzania. I. Impact of maternal syphilis on outcome of pregnancy. J Infect Dis 186: 940–947.
4. NewmanL, KambM, HawkesS, GomezG, SayL, et al. (2013) Global estimates of syphilis in pregnancy and associated adverse outcomes: analysis of multinational antenatal surveillance data. PLoS Med 10: e1001396 doi:10.1371/journal.pmed.1001396
5. GomezGB, KambML, NewmanLM, MarkJ, BroutetN, et al. (2013) Untreated maternal syphilis and adverse outcomes of pregnancy: a systematic review and meta-analysis. Bull World Health Organ 91: 217–226.
6. GloydS, ChaiS, MercerMA (2001) Antenatal syphilis in sub-Saharan Africa: missed opportunities for mortality reduction. Health Policy Plan 16: 29–34.
7. RydzakCE, GoldieSJ (2008) Cost-effectiveness of rapid point-of-care prenatal syphilis screening in sub-Saharan Africa. Sex Transm Dis 35: 775–784.
8. US Centers for Disease Control and Prevention (2010) Diseases characterized by genital, anal, or perianal ulcers. Atlanta (Georgia, US): US Centers for Disease Control and Prevention.
9. HerringA, BallardR, MabeyD, PeelingRW (2006) WHO/TDR Sexually Transmitted Diseases Diagnostics Initiative (2006) Evaluation of rapid diagnostic tests: syphilis. Nat Rev Microbiol 4 (Suppl 12) S33–S40.
10. WorkowskiKA, BermanS (2010) Centers for Disease Control and Prevention (2010) Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep 59: 1–110.
11. Watson-JonesD, GumodokaB, WeissH, ChangaluchaJ, ToddJ, et al. (2002) Syphilis in pregnancy in Tanzania. II. The effectiveness of antenatal syphilis screening and single-dose benzathine penicillin treatment for the prevention of adverse pregnancy outcomes. J Infect Dis 186: 948–957.
12. SenaAC, WhiteBL, SparlingPF (2010) Novel Treponema pallidum serologic tests: a paradigm shift in syphilis screening for the 21st century. Clin Infect Dis 51: 700–708.
13. ZarakoluP, BuchananI, TamM, SmithK, HookEW3rd (2002) Preliminary evaluation of an immunochromatographic strip test for specific Treponema pallidum antibodies. J Clin Microbiol 40: 3064–3065.
14. JafariY, PeelingRW, ShivkumarS, ClaessensC, JosephL, et al. (2013) Are Treponema pallidum specific rapid and point-of-care tests for syphilis accurate enough for screening in resource limited settings? Evidence from a meta-analysis. PLoS ONE 8: e54695 doi:10.1371/journal.pone.0054695
15. TuckerJD, BuJ, BrownLB, YinYP, ChenXS, et al. (2010) Accelerating worldwide syphilis screening through rapid testing: a systematic review. Lancet Infect Dis 10: 381–386.
16. United Nations Children's Fund (2010) Statistics and monitoring. New York: United Nations Children's Fund.
17. World Health Organization (2011) Choosing interventions that are cost effective (WHO-CHOICE). Cost-effectiveness thresholds. Geneva: World Health Organization.
18. MurrayCJ, LopezAD (1996) Evidence-based health policy—lessons from the Global Burden of Disease Study. Science 274: 740–743.
19. World Health Organization, Joint United Nations Programme on HIV/AIDS, United Nations Children's Fund (2011) Global HIV/AIDS response: epidemic update and health sector progress towards universal access. Geneva: World Health Organization.
20. MabeyDC, SollisKA, KellyHA, BenzakenAS, BitarakwateE, et al. (2012) Point-of-care tests to strengthen health systems and save newborn lives: the case of syphilis. PLoS Med 9: e1001233 doi:10.1371/journal.pmed.1001233
21. StrasserS, BitarakwateE, GillM, HoffmanHJ, MusanaO, et al. (2012) Introduction of rapid syphilis testing within prevention of mother-to-child transmission of HIV programs in Uganda and Zambia: a field acceptability and feasibility study. J Acquir Immune Defic Syndr 61: e40–e46.
22. World Bank (2013) GNI per capita, Atlas method (current US$). Washington (District of Columbia): World Bank. Available: http://data.worldbank.org/indicator/NY.GNP.PCAP.CD. Accessed 4 October 2013.
23. World Health Organization (2002) HIV/AIDS epidemiological surveillance update for the WHO African Region. Harare (Zimbabwe): World Health Organization.
24. World Health Organization (2007) HIV/AIDS epidemiological surveillance update for the WHO African Region. Harare (Zimbabwe): World Health Organization.
25. HawkesS, MatinN, BroutetN, LowN (2011) Effectiveness of interventions to improve screening for syphilis in pregnancy: a systematic review and meta-analysis. Lancet Infect Dis 11: 684–691.
26. World Health Organization (2006) Neonatal and perinatal mortality: country, regional and global estimates. Geneva: World Health Organization.
27. Alibaba.com (2013) Treponema test kit [internet search result]. Available: http://www.alibaba.com/products/F0/treponema_test_kit.html. Accessed 1 October 2013.
28. LevinCE, SteeleM, AtherlyD, GarciaSG, TinajerosF, et al. (2007) Analysis of the operational costs of using rapid syphilis tests for the detection of maternal syphilis in Bolivia and Mozambique. Sex Transm Dis 34: S47–S54.
29. SchackmanBR, NeukermansCP, FontainSN, NolteC, JosephP, et al. (2007) Cost-effectiveness of rapid syphilis screening in prenatal HIV testing programs in Haiti. PLoS Med 4: e183 doi:10.1371/journal.pmed.0040183
30. HiraSK, BhatGJ, ChikamataDM, NkowaneB, TemboG, et al. (1990) Syphilis intervention in pregnancy: Zambian demonstration project. Genitourin Med 66: 159–164.
31. JenniskensF, ObwakaE, KirisuahS, MosesS, Mohamedali YusufaliF, et al. (1995) Syphilis control in pregnancy: decentralization of screening facilities to primary care level, a demonstration project in Nairobi, Kenya. Int J Gynaecol Obstet 48: 121–128.
32. FonckK, ClaeysP, BashirF, BwayoJ, FransenL, et al. (2001) Syphilis control during pregnancy: effectiveness and sustainability of a decentralized program. Am J Public Health 91: 705–707.
33. Terris-PrestholtF, Watson-JonesD, MugeyeK, KumaranayakeL, NdekiL, et al. (2003) Is antenatal syphilis screening still cost effective in sub-Saharan Africa. Sex Transm Infect 79: 375–381.
34. VickermanP, PeelingRW, Terris-PrestholtF, ChangaluchaJ, MabeyD, et al. (2006) Modelling the cost-effectiveness of introducing rapid syphilis tests into an antenatal syphilis screening programme in Mwanza, Tanzania. Sex Transm Infect 82 (Suppl 5) v38–v43.
35. Owusu-EduseiK, GiftTL, BallardRC (2011) Cost-effectiveness of a dual non-treponemal/treponemal syphilis point-of-care test to prevent adverse pregnancy outcomes in sub-Saharan Africa. Sex Transm Dis 38: 997–1003.
36. National Institute for Health and Care Excellence (2010) Antenatal care. NICE clinical guideline 62. Issued: March 2008 last modified: June 2010. London: National Institute for Health and Care Excellence.
37. MyerL, KarimSSA, LombardC, WilkinsonD (2004) Treatment of maternal syphilis in rural South Africa: effect of multiple doses of benzathine penicillin on pregnancy loss. Trop Med Int Health 9: 1216–1221.
38. MyerL, WilkinsonD, LombardC, ZumaK, RotchfordK, et al. (2003) Impact of on-site testing for maternal syphilis on treatment delays, treatment rates, and perinatal mortality in rural South Africa: a randomised controlled trial. Sex Transm Infect 79: 208–213.
39. Joint Task Force on Practice Parameters; American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology (2010) Drug allergy: an updated practice parameter. Ann Allergy Asthma Immunol 105: 259–273.
40. World Health Organization (2011) The Abuja declaration: ten years on. Geneva: World Health Organization.
41. Joint United Nations Programme on HIV/AIDS, United Nations Children's Fund, United Nations Population Fund, World Health Organization (2011) Elimination of new paediatric HIV infections and congenital syphilis in Asia-Pacific, 2011–2015. Bangkok: UNICEF East Asia and Pacific Regional Office.
42. World Health Organization (2012) Investment case for elimination mother-to-child transmission of syphilis: promoting better maternal and child health and stronger health systems. Geneva: World Health Organization. 30 p.
43. SchefflerRM, MahoneyCB, FultonBD, Dal PozMR, PrekerAS (2009) Estimates of health care professional shortages in sub-Saharan Africa by 2015. Health Aff (Millwood) 28: w849–w862.
44. Botswana Ministry of Education and Skills Development (2012) Vacancy circular No 3 of 2012. Gaborone: Botswana Ministry of Education and Skills Development.
45. Tejiokem MC, Tene G, Ayouba J, Koagne L, Foude M, et al. (2004) Evolution of HIV-1 and syphilis prevalence among pregnant women attending antenatal clinic in Yaounde, Cameroon: results from a pilot public health program, 2000–2003 [abstract]. Abstract no MoPeC3589. XV International AIDS Conference; 11–16 July 2004; Bangkok, Thailand.
46. HuttonG, WyssK, N''DiekhorY (2003) Prioritization of prevention activities to combat the spread of HIV/AIDS in resource constrained settings: a cost-effectiveness analysis from Chad, Central Africa. Int J Health Plann Manage 18: 117–136.
47. National Bureau of Economics Research (2013) Occupational Wages around the World (OWW) Database [database]. Available: http://data.nber.org/oww/. Accessed 1 October 2013.
48. DialloMO, Ettiegne-TraoreV, MaranM, KouadioJ, BrattegaardK, et al. (1997) Sexually transmitted diseases and human immunodeficiency virus infections in women attending an antenatal clinic in Abidjan, Côte d'Ivoire. Int J STD AIDS 8: 636–638.
49. DyerE (2002) Nursing in Goma, Congo. Am J Nurs 102: 87, 89, 91.
50. World Health Organization (2001) Global prevalence and incidence of selected curable sexually transmitted infections: overview and estimates. Geneva: World Health Organization.
51. BertheratE, Georges-CourbotMC, NabiasR, GeorgesAJ, RenautA (1998) Seroprevalence of four sexually transmitted diseases in a semi-urban population of Gabon. Int J STD AIDS 9: 31–36.
52. TemmermanM, GichangiP, FonckK, ApersL, ClaeysP, et al. (2000) Effect of a syphilis control programme on pregnancy outcome in Nairobi, Kenya. Sex Transm Infect 76: 117–121.
53. VarpilahST, SaferM, FrenkelE, BabaD, MassaquoiM, et al. (2011) Rebuilding human resources for health: a case study from Liberia. Hum Resour Health 9: 11.
54. TaiwoSS, AdesijiYO, AdekanleDA (2007) Screening for syphilis during pregnancy in Nigeria: a practice that must continue. Sex Transm Infect 83: 357–358.
55. McCoyD, BennettS, WitterS, PondB, BakerB, et al. (2008) Salaries and incomes of health workers in sub-Saharan Africa. Lancet 371: 675–681.
56. Ndiaye A, Angono MZ, Diouf G, Diouf ED, Sambou D, et al. (2002) Prevalence of HIV and syphilis infection in pregnant women to Catholic Centers around Dakar [abstract]. XIV International AIDS Conference; 7–12 July 2002; Barcelona, Spain.
57. VujicicM, ZurnP, DialloK, AdamsO, Dal PozMR (2004) The role of wages in the migration of health care professionals from developing countries. Hum Resour Health 2: 3.
58. PolgreenL (2012 August 1) Outside a king's plush halls, streets rise in anger. The New York Times A6.
59. SongstadNG, RekdalOB, MassayDA, BlystadA (2011) Perceived unfairness in working conditions: the case of public health services in Tanzania. BMC Health Serv Res 11: 34.
60. PhamL, WoelkGB, NingY, MadzimeS, MudzamiriS, et al. (2005) Seroprevalence and risk factors of syphilis infection in pregnant women delivering at Harare Maternity Hospital, Zimbabwe. Cent Afr J Med 51: 24–30.
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2013 Číslo 11
- Statiny indukovaná myopatie: Jak na diferenciální diagnostiku?
- MUDr. Dana Vondráčková: Hepatopatie sú pri liečbe metamizolom väčším strašiakom ako agranulocytóza
- Vztah mezi statiny a rizikem vzniku nádorových onemocnění − metaanalýza
- Nech brouka žít… Ať žije astma!
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
Najčítanejšie v tomto čísle
- A Brief Patient-Reported Outcomes Quality of Life (PROQOL) Instrument to Improve Patient Care
- Burden of Depressive Disorders by Country, Sex, Age, and Year: Findings from the Global Burden of Disease Study 2010
- From Ideals to Tools: Applying Human Rights to Maternal Health
- Role of DNA Methylation and Epigenetic Silencing of in Endometrial Cancer Development